NAD+ BENEFITS Selective NNMT inhibition substrate-site targeting with minimal off-target activity in preclinical models NAD+ salvage modulation studied for increasing intracellular NAD+ and SAM availability Adipose metabolism investigated for suppression of adipocyte lipogenesis in 3T3-L1 models Small molecule distinct mechanism from peptide-based metabolic compounds (GLP-1 agonists, etc.) Defined pharmacology IC of 1.2 M confirmed in published enzymatic assays WHAT RESEARCHERS LOOK AT NNMT enzyme inhibition kinetics and SAM/1-MNA substrate balance NAD+ and SAM level changes in adipocyte and hepatocyte cell models Lipogenesis suppression in 3T3-L1 differentiated adipocyte assays Polyamine flux enzyme upregulation (ODC, SSAT) and histone methylation In vivo efficacy in diet-induced obesity (DIO) murine models

Histological analysis of healed tissue is used to assess collagen organization and scar morphology, providing insights into the peptide's potential to promote regenerative, rather than fibrotic, repair
Gastrointestinal effects are the most common and include nausea, vomiting, diarrhea, and constipation
CJC-1295, ipamorelin, and AOD-9604 were each PCAC-rejected in late 2024 and currently have no 503A compounding pathway
Use your voice and hands to praise and caress the cat and reassure them that all is well